Loading stock data…
Autonomix Medical, Inc. (AMIX)
$4.58-0.01 (-0.22%)
After Hours$4.51-0.07 (-1.53%)· Last close Sep 8
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Autonomix Medical, Inc. in the Healthcare sector is trading at $4.58 with a market capitalization of $4M. Wall Street consensus targets $58.80 (2 analysts), implying a +1183.8% move over the next 12 months. The stock is currently near its 52-week low of $2.44, remaining 49.2% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply +1183.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.77M↓ | -$2.74M↑ | -$3.34M↑ | -$7.53M↓ | -$3.42M |
| Net Income | -$2.73M↓ | -$2.67M↑ | -$3.26M↑ | -$7.45M↓ | -$3.34M |
Peer Comparison
JNJUNHPFE
Fundamentals
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-en...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.45M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.99
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-509.36%
Volume
Today's trading volume
73,442
Recent News
Top Midday Gainers
707 Cayman (JEM) entered a non-binding term sheet to acquire Crucial Innovation to advance its expan
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
Autonomix Medical (NASDAQ:AMIX) expanded its intellectual property portfolio with a new U. S.
BC-Most Active Stocks
td class="col-issue">New Era Energy & Digital Inc.